Quick Heal Technologies Ltd

Q4 FY25IT - Software

Quick Heal Technologies Q4 FY25: Revenue ₹65.1 Cr, PAT ₹3.3 Cr

Q4 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹148

Market cap₹827 Cr

Updated24 Sept 2026

Read3 min read

Based on Quick Heal Technologies Ltd's Q4 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. Q4 FY25 EBITDA: -₹8.5 Cr (down from ₹10.0 Cr in Q4 FY24) - Q4 FY25 EBITDA Margin: -13.0% (down from 12.6% in Q4 FY24) - Q4 FY25 Profit After Tax (PAT): -₹3.3 Cr (down from ₹14.0 Cr in Q4 FY24) - Q4 FY25 PAT Margin: -5.0% (down from 17.5% in Q4 FY24) Year-on-Year changes indicate a significant decline in profitability and margins compared to the same quarter previous year.

From Quick Heal Technologies Ltd's Q4 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. -18.6% YoY) (Page 31)
FY25 Revenue: ₹279.5 Cr, down from ₹291.8 Cr in FY24 (-4.2% YoY) (Page 24, 31)
Consumer Revenue FY25: ₹185.7 Cr, down 9.2% YoY (Page 25, 24)
Enterprise Revenue FY25: ₹121.2 Cr, up 1.5% YoY (Page 24)

2 more points management made on revenue & sales performance

Profitability & Margins

Q4 FY25 EBITDA: -₹8.5 Cr (down from ₹10.0 Cr in Q4 FY24)
Q4 FY25 EBITDA Margin: -13.0% (down from 12.6% in Q4 FY24)
Q4 FY25 Profit After Tax (PAT): -₹3.3 Cr (down from ₹14.0 Cr in Q4 FY24)

2 more points management made on profitability & margins

See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The presentation does not explicitly mention any capex, capacity expansion, or new plant/project details including amounts, statuses, or timelines. - Capital work-in-progress decreased from ₹3.1 Cr (Mar 31, 2024) to ₹0.1 Cr (Mar 31, 2025), indicating minimal ongoing capital projects. - Property, plant & equipment values remained stable (₹83.6 Cr to ₹83.2 Cr). - Investment property increased slightly from ₹31.6 Cr to ₹35.0 Cr, but no specific expansion or new plant/project details are provided. No direct references to capex plans, capacity expansions, or new plant/project launches with amounts or timelines are found in the provided content.

Top-ranked in IT - Software

Ranked on what management guided this quarter

5x potential

1Workmates Core2cloud Solution Ltd₹536 Cr

Rev 1Mar 1

2Virtual Galaxy₹361 Cr

Rev 1Mar 3

3₹194 Cr

Rev 2Mar 1

4₹140 Cr

Rev 2Mar 1

5₹2.0K Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation does not mention any fundraising through debt or equity.
There is no explicit reference to any new borrowings or changes in borrowings.
Finance Cost remains minimal and stable at (0.1) to (0.2) Cr across FY24 and FY25, indicating no significant debt increase (Page 31).
Balance Sheet (Page 32) shows no long-term borrowings under non-current liabilities; only "Other Non Current Liabilities" and employee benefits liabilities are present.

2 more points management made on fundraising & capital structure

See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order Book: INR 24+ Cr as on date (Page 20, Business Highlights)
New Product Billing: FY25 > 3x FY24 (Page 20)
Deferred Revenue: INR 12+ Cr (Page 20)
First order for Seqrite Threat Intelligence received (Page 20)

Quick Heal Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹49 Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Quick Heal Tech's management said in earlier quarters

Others in IT - Software this season

ASM Technologies Ltd (Q4 FY25)
Q4 FY24: ₹445.92 million . Key concall takeaways from ASM Technologies Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
Olatech Solution (Q4 FY25)
Current order book in hand: ₹35 crores (as of June 2025). Key concall takeaways from Olatech Solutions Ltd's Q4 FY25 earnings call — and how it ranks against…
Birlasoft Ltd (Q4 FY25)
The company has a strong cash position with cash and cash equivalents growing 24% YoY to $259.5 million as of FY25 end. Key concall takeaways from Birlasoft…
Wipro Ltd (Q4 FY25)
FY25 experienced a 2.3% decline in IT Services revenue (constant currency); Q4 saw a sequential decline of 0.8%. Key concall takeaways from Wipro Ltd's Q4 FY25…

Compare:vs Tata Consultancy Services Ltd vs Infosys Ltd vs HCL Technologies Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Quick Heal Technologies Ltd Q4 FY25 results?

What is Quick Heal Technologies Ltd share price analysis?

Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹827 Cr. Investors should review the full earnings analysis for detailed insights.

Is Quick Heal Technologies Ltd planning capital expenditure?

The presentation does not explicitly mention any capex, capacity expansion, or new plant/project details including amounts, statuses, or timelines.

Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.